66 Deals over a Five Year Period Analyzed for Schering-Plough Corporation Deals Briefing.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26125 ) has announced the addition of Schering-Plough Corporation Deals Briefing to their offering.

Description

Schering-Plough Corporation Deals Briefing provides an in-depth view of the 66 deals made by Schering-Plough Corporation and its subsidiaries with 75 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Chapter 1: Company profile

--An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

--A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

--A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

--A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.

*Pharmaceutical Executive Top 50, May 2005

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

--a brief company profile including subsidiary names

--financial information where disclosed

--a deals overview

--specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage

--a detailed listing of the company's deals and alliances.

Key questions answered

--Schering-Plough Corporation Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

--identifying active partners

--tracking competitor activity

--benchmarking deals

--comparing the finances of different deal types.

Schering-Plough Corporation Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Schering-Plough Corporation.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who the report is aimed at

This report is essential reading for board and executive management, and individuals in:

--business development

--licensing/partnering

--deal making

--business strategy

--marketing and promotion

--distribution and manufacturing (including contract services).

Topics Covered

--Introduction

--About Partneringdesk Deals briefings

--Chapter 1: Company profile

--Chapter 2: Financial data and deals overview

--Chapter 3: Summary of deals

--Deals involving Schering-Plough Corporation by partner company

--Deals involving Schering-Plough Corporation by subsidiary

--Deals involving Schering-Plough Corporation by therapy focus

--Deals involving Schering-Plough Corporation by development stage

--Chapter 4: List of deals

--Glossary

--List of Tables and Charts

Companies Mentioned

--DNAX Research

--NeoGenesis

--Schering-Plough Animal Health Corporation

--Schering-Plough HealthCare Products

--Schering-Plough Research Institute (SPRI)

--Takeda Schering-Plough Animal Health KK

For more information visit http://www.researchandmarkets.com/reports/c26125.